Samuel Dagogo-Jack, chief of the division of endocrinology, metabolism, and diabetes at the University of Tennessee Health Science Center in Memphis, has received the 2024 Outstanding Achievement in Clinical Diabetes Research Award from the American Diabetes Association. The annual award recognizes Dr. Dagogo-Jack’s significant contributions to diabetes prevention and treatment research, as well as his insights into the pathobiology of prediabetes.
With over three decades of experience in clinical treatment research, Dr. Dagogo-Jack holds numerous academic and administrative positions at the University of Tennessee Health Science Center. In addition to heading the endocrinology, metabolism, and diabetes division, he serves as the senior associate vice chancellor for clinical research and director of the general clinical research center. He currently holds the title of A. C. Mullins Endowed Professorial Chair in Translational Research. Earlier in his career, he held teaching appointments with the University of Mississippi Medical Center, Washington University in St. Louis, Missouri, and the University of Port Harcourt in Nigeria.
Currently, Dr. Dagogo-Jack’s research interests center around the interaction of genetic and environmental factors in the prediction and prevention of prediabetes, diabetes, and related complications. His research has led to numerous publications including Prediabetes: A Fundamental Text: Pathophysiology, Complications, Management, & Reversal (America Diabetes Association, 2021). In addition to his academic pursuits, he is a practicing physician with the Methodist University Hospital and Regional Medical Center in Memphis, Tennessee.
Dr. Dagogo-Jack received dual-bachelor’s degrees in medicine and surgery, respectively, a medical degree, and a doctor of science degree from the University of Ibadan in Nigeria. He holds a master’s degree in medical science from the University of Newcastle in the United Kingdom and an MBA from the University of Tennessee.
